Decision tool
Treatment explorer
Explore treatments by cancer type, standard or advanced level, and category. Each entry shows recorded links to biomarkers and medicines.
What you get
Learn treatment categories so terms in a report are easier to read.
Explore treatments by cancer and category, with recorded biomarker links.
A recorded link is not a recommendation
16 treatments match these filters
- StandardSurgery
Surgery (oncologic surgery)
Removal of a tumour through surgery, often part of a plan intended to cure early-stage solid cancers.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- StandardRadiotherapy
Radiotherapy
Use of directed radiation to kill or control cancer cells in a specific area.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedRadiotherapy
SBRT (stereotactic radiotherapy)
Highly targeted high-dose radiotherapy delivered in a small number of sessions to a small, clear target.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- StandardChemotherapy
Chemotherapy
Systemic cytotoxic drugs that act on rapidly dividing cells, given in scheduled cycles.
Related biomarkers: none recorded yet.
Related medicines: Cisplatin, Capecitabine, Oxaliplatin, Trastuzumab deruxtecan
- AdvancedTargeted therapy
Targeted therapy
Drugs that act on a specific molecular marker in cancer cells, selected based on biomarker test results.
Related biomarkers: EGFR, ALK, ROS1, KRAS, MET, RET, BRAF, HER2, NTRK, CLDN18.2
Related medicines: Osimertinib, Alectinib, Lorlatinib, Sotorasib, Tepotinib, Selpercatinib, Trastuzumab deruxtecan, Zolbetuximab, Dabrafenib, Trametinib
- AdvancedImmunotherapy
Immunotherapy
Treatment that helps the immune system recognise and attack cancer cells, usually through immune checkpoint inhibitors.
Related biomarkers: PD-L1, MSI / MMR
Related medicines: Pembrolizumab, Nivolumab, Ipilimumab, Atezolizumab, Durvalumab, Cemiplimab, Dostarlimab, Rituximab, Glofitamab, Daratumumab, Teclistamab
- AdvancedCellular therapy
CAR-T (chimeric antigen receptor T-cell therapy)
Cellular therapy that modifies a patient's T cells so they recognise a marker on cancer cells, then returns them to the patient's body.
Related biomarkers: CD19, Del(17p) / TP53
Related medicines: Axicabtagene ciloleucel, Tisagenlecleucel, Brexucabtagene autoleucel, Idecabtagene vicleucel, Ciltacabtagene autoleucel
- AdvancedTransplant
Stem cell transplant
Infusion of haematopoietic stem cells after high-dose therapy or as part of recovery, to restore blood production.
Related biomarkers: Del(17p) / TP53
Related medicines: Lenalidomide, Bortezomib, Daratumumab
- AdvancedIntervention
Oncology intervention (interventional radiology)
Minimally invasive image-guided procedures for diagnosis, local therapy, or complication management.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedRadionuclide therapy
Radionuclide therapy (radioligand therapy)
Drugs that carry radiation to a specific target on cancer cells through a binding molecule.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- StandardIntervention
Supportive and palliative care
Management of symptoms, pain, and daily needs alongside cancer treatment.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedRadiotherapy
SRS (intracranial stereotactic radiotherapy)
High-dose, high-precision radiotherapy for lesions in the brain, usually in one or a few sessions.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedRadiotherapy
Precision radiotherapy (IMRT and VMAT)
Intensity-modulated radiotherapy that shapes the dose to the tumour contour so nearby healthy tissue is better protected.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedRadiotherapy
Proton therapy
Radiotherapy using proton particles that stop their energy at the target depth, so healthy tissue beyond the target receives a very low dose.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedCellular therapy
TIL (tumour-infiltrating lymphocyte therapy)
Cellular therapy that expands lymphocytes already present inside the patient's tumour, then returns them after preparatory therapy.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
- AdvancedCellular therapy
TCR-T (engineered T-cell receptor therapy)
Cellular therapy that gives a patient's T cells a special receptor so they can recognise fragments of tumour protein on the cell surface.
Related biomarkers: none recorded yet.
Related medicines: none recorded yet.
Not a diagnosis and not final medical advice. Must be reviewed by a doctor.